Angiogenesis inhibition: quo vadis?

Editorial

Michael Weller. Neuro Oncol. 2012 Nov.

. 2012 Nov;14(11):1315.

doi: 10.1093/neuonc/nos274.

No abstract available

Comment on

Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype.
Piao Y, Liang J, Holmes L, Zurita AJ, Henry V, Heymach JV, de Groot JF. Piao Y, et al. Neuro Oncol. 2012 Nov;14(11):1379-92. doi: 10.1093/neuonc/nos158. Epub 2012 Sep 10. Neuro Oncol. 2012. PMID: 22965162 Free PMC article.

1. Piao Y, Liang J, Holmes L, et al. Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation and a mesenchymal phenotype. Neuro-Oncology. 2012;14(11):1378–1391. - PMC - PubMed